Key result
The ADHERE-App improved short-term medication adherence in atrial fibrillation, but its applicability is limited by a 6-month follow-up and exclusion of older adults with low digital literacy.
Why the study?
Does a smartphone app improve medication adherence to edoxaban in patients with atrial fibrillation?
Does a smartphone app improve medication adherence to edoxaban in patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
This letter highlights the need for broader inclusivity, longer follow-up, and more precise adherence metrics in digital health interventions for atrial fibrillation patients on anticoagulants.
-
No takes yet. Share an insight, caveat, or question.
Shanshan Du (2025) conducted a letter in Atrial fibrillation. Smartphone App (ADHERE-App) was evaluated. The ADHERE-App improved short-term medication adherence in atrial fibrillation, but its applicability is limited by a 6-month follow-up and exclusion of older adults with low digital literacy.
Synapse has enriched 10 related papers. Consider them for comparative context: